From: Anita_Newman@cdh.org
Sent: Wednesday, September 04, 2002 8:07 PM
To: fdadockets@oc.fda.gov
Subject: Pharmaceutical Advertising

I recently read that pharmaceutical manufacturers now spend MORE on direct
advertising to the public than they do on research and development.  In the
same breath, pharmaceutical manufacturers decry attempts to influence their
pricing policies stating that price controls would stifle the research and
development necessary to bring new and needed products to the marketplace.
Which shall it be?  I'm very tired of the pharmaceutical manufacturers,
their domestic and over-seas pricing discrepancies, and their
direct-to-consumer advertising.  Anita Newman, 1401 Queensgreen Circle,
Naperville, IL 60563